Advances in Lung Cancer Treatments

Session 5 -- presented by Dr David Carbone MD PhD, USA

Dr David Carbone is Professor of Internal Medicine, and currently Director of the James Thoracic Center at the Ohio State University. His eminent research career centres around research projects and publications focused on lung cancer, and specifically proteomic and expression array signature development, lung cancer genetics, cancer immunotherapy, tumor-associated immunosuppression mechanisms and gene therapy. Recent research directions include development of molecular biomarkers to guide patient management and therapy, and molecular profiling of lung cancers and preneoplasias to guide the development of novel therapeutics, especially using mass spectrometry-based proteomics.